{"id":2361,"date":"2024-05-02T15:16:53","date_gmt":"2024-05-02T15:16:53","guid":{"rendered":"https:\/\/stoxpo.com\/?p=2361"},"modified":"2024-05-02T15:16:54","modified_gmt":"2024-05-02T15:16:54","slug":"moderna-reports-narrower-loss-amid-decline-in-covid-vaccine-sales","status":"publish","type":"post","link":"https:\/\/stoxpo.com\/index.php\/2024\/05\/02\/moderna-reports-narrower-loss-amid-decline-in-covid-vaccine-sales\/","title":{"rendered":"Moderna Reports Narrower Loss Amid Decline in Covid Vaccine Sales"},"content":{"rendered":"\n<h4 class=\"wp-block-heading\">Biotech Company Reiterates Sales Guidance, Anticipates Launch of RSV Vaccine<\/h4>\n\n\n\n<p class=\"wp-block-paragraph\">Moderna (MRNA), the biotech company at the forefront of Covid vaccine development, posted a narrower-than-expected loss for the first quarter as cost-cutting efforts and stronger-than-expected sales of its Covid vaccine bolstered its financial performance. Despite the decline in revenue from its flagship Covid shot, Moderna&#8217;s results were buoyed by progress in its operational efficiencies and anticipation surrounding the potential launch of its vaccine against respiratory syncytial virus (RSV).<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The company reported a loss per share of $3.07, surpassing analysts&#8217; expectations of a loss of $3.58, while its revenue of $167 million exceeded estimates of $97.5 million. Moderna&#8217;s CEO, St\u00e9phane Bancel, highlighted the significant progress made in reducing operating expenses, underscoring the company&#8217;s resilience amidst shifting market dynamics.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Moderna&#8217;s outlook remains positive as it anticipates U.S. approval for its RSV vaccine on May 12, with expectations of a third-quarter launch. The company reiterated its full-year 2024 sales guidance of approximately $4 billion, which includes revenue from the RSV vaccine. While revenue from the Covid vaccine is expected to continue declining, Moderna is optimistic about its future growth prospects, aiming to return to sales growth in 2025 and achieve breakeven by 2026 with the introduction of new products.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Despite challenges posed by the transition to a seasonal Covid vaccine market, Moderna remains committed to innovation and operational excellence, leveraging AI technologies and digital commercial capabilities to drive efficiency and enhance its competitive position in the biotech industry.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">You might like this article:<a href=\"https:\/\/stoxpo.com\/index.php\/2024\/05\/01\/chip-stocks-tumble-as-amd-and-super-micro-computer-miss-earnings-expectations\/\"><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-vivid-cyan-blue-color\">Chip Stocks Tumble as AMD and Super Micro Computer Miss Earnings Expectations<\/mark><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Biotech Company Reiterates Sales Guidance, Anticipates Launch of RSV Vaccine Moderna (MRNA), the biotech company at the forefront of Covid vaccine development, posted a narrower-than-expected loss for the first quarter as cost-cutting efforts and stronger-than-expected sales of its Covid vaccine bolstered its financial performance. Despite the decline in revenue from its flagship Covid shot, Moderna&#8217;s [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":1412,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"jnews-multi-image_gallery":[],"jnews_single_post":{"subtitle":"","format":"standard","video":"","gallery":"","source_name":"","source_url":"","via_name":"","via_url":"","override_template":"0","override":[{"template":"8","single_blog_custom":"","parallax":"1","fullscreen":"1","layout":"right-sidebar-narrow","sidebar":"author","second_sidebar":"single-right","sticky_sidebar":"1","share_position":"top","share_float_style":"share-monocrhome","show_share_counter":"0","show_view_counter":"0","show_featured":"1","show_post_meta":"1","show_post_author":"1","show_post_author_image":"0","show_post_date":"1","post_date_format":"default","post_date_format_custom":"Y\/m\/d","show_post_category":"1","show_post_reading_time":"1","post_reading_time_wpm":"300","show_zoom_button":"0","zoom_button_out_step":"2","zoom_button_in_step":"3","show_post_tag":"1","show_prev_next_post":"1","show_popup_post":"1","number_popup_post":"1","show_author_box":"0","show_post_related":"1","show_inline_post_related":"0"}],"override_image_size":"0","image_override":[{"single_post_thumbnail_size":"crop-500","single_post_gallery_size":"crop-500"}],"trending_post":"0","trending_post_position":"meta","trending_post_label":"Trending","sponsored_post":"0","sponsored_post_label":"Sponsored by","sponsored_post_name":"","sponsored_post_url":"","sponsored_post_logo_enable":"0","sponsored_post_logo":"","sponsored_post_desc":"","disable_ad":"0"},"jnews_primary_category":{"id":"","hide":""},"jnews_social_meta":{"fb_title":"","fb_description":"","fb_image":"","twitter_title":"","twitter_description":"","twitter_image":""},"jnews_override_counter":{"override_view_counter":"0","view_counter_number":"0","override_share_counter":"0","share_counter_number":"0","override_like_counter":"0","like_counter_number":"0","override_dislike_counter":"0","dislike_counter_number":"0"},"jnews_post_split":{"enable_post_split":"0","post_split":[{"template":"1","tag":"h2","numbering":"asc","mode":"normal","first":"0","enable_toc":"0","toc_type":"normal"}]},"footnotes":""},"categories":[308,361],"tags":[],"coauthors":[454],"class_list":["post-2361","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-biotechnology","category-large-cap"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Moderna Reports Narrower Loss Amid Decline in Covid Vaccine Sales - Stoxpo<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/stoxpo.com\/index.php\/2024\/05\/02\/moderna-reports-narrower-loss-amid-decline-in-covid-vaccine-sales\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Moderna Reports Narrower Loss Amid Decline in Covid Vaccine Sales - Stoxpo\" \/>\n<meta property=\"og:description\" content=\"Biotech Company Reiterates Sales Guidance, Anticipates Launch of RSV Vaccine Moderna (MRNA), the biotech company at the forefront of Covid vaccine development, posted a narrower-than-expected loss for the first quarter as cost-cutting efforts and stronger-than-expected sales of its Covid vaccine bolstered its financial performance. Despite the decline in revenue from its flagship Covid shot, Moderna&#8217;s [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/stoxpo.com\/index.php\/2024\/05\/02\/moderna-reports-narrower-loss-amid-decline-in-covid-vaccine-sales\/\" \/>\n<meta property=\"og:site_name\" content=\"Stoxpo\" \/>\n<meta property=\"article:published_time\" content=\"2024-05-02T15:16:53+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-05-02T15:16:54+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/pexels-mufid-majnun-9240711-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1707\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Luca Blaumann\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Luca Blaumann\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/05\\\/02\\\/moderna-reports-narrower-loss-amid-decline-in-covid-vaccine-sales\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/05\\\/02\\\/moderna-reports-narrower-loss-amid-decline-in-covid-vaccine-sales\\\/\"},\"author\":{\"name\":\"Luca Blaumann\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#\\\/schema\\\/person\\\/031a96817fc4447b1046e0a10baad806\"},\"headline\":\"Moderna Reports Narrower Loss Amid Decline in Covid Vaccine Sales\",\"datePublished\":\"2024-05-02T15:16:53+00:00\",\"dateModified\":\"2024-05-02T15:16:54+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/05\\\/02\\\/moderna-reports-narrower-loss-amid-decline-in-covid-vaccine-sales\\\/\"},\"wordCount\":269,\"publisher\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/05\\\/02\\\/moderna-reports-narrower-loss-amid-decline-in-covid-vaccine-sales\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/stoxpo.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/pexels-mufid-majnun-9240711-scaled.jpg\",\"articleSection\":[\"Biotechnology\",\"Large-Cap\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/05\\\/02\\\/moderna-reports-narrower-loss-amid-decline-in-covid-vaccine-sales\\\/\",\"url\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/05\\\/02\\\/moderna-reports-narrower-loss-amid-decline-in-covid-vaccine-sales\\\/\",\"name\":\"Moderna Reports Narrower Loss Amid Decline in Covid Vaccine Sales - Stoxpo\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/05\\\/02\\\/moderna-reports-narrower-loss-amid-decline-in-covid-vaccine-sales\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/05\\\/02\\\/moderna-reports-narrower-loss-amid-decline-in-covid-vaccine-sales\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/stoxpo.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/pexels-mufid-majnun-9240711-scaled.jpg\",\"datePublished\":\"2024-05-02T15:16:53+00:00\",\"dateModified\":\"2024-05-02T15:16:54+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/05\\\/02\\\/moderna-reports-narrower-loss-amid-decline-in-covid-vaccine-sales\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/05\\\/02\\\/moderna-reports-narrower-loss-amid-decline-in-covid-vaccine-sales\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/05\\\/02\\\/moderna-reports-narrower-loss-amid-decline-in-covid-vaccine-sales\\\/#primaryimage\",\"url\":\"https:\\\/\\\/stoxpo.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/pexels-mufid-majnun-9240711-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/stoxpo.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/pexels-mufid-majnun-9240711-scaled.jpg\",\"width\":2560,\"height\":1707,\"caption\":\"moderna-vaccine-2\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/05\\\/02\\\/moderna-reports-narrower-loss-amid-decline-in-covid-vaccine-sales\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/stoxpo.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Moderna Reports Narrower Loss Amid Decline in Covid Vaccine Sales\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#website\",\"url\":\"https:\\\/\\\/stoxpo.com\\\/\",\"name\":\"Stoxpo\",\"description\":\"Stock Market &amp; Financial News\",\"publisher\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/stoxpo.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#organization\",\"name\":\"Stoxpo\",\"url\":\"https:\\\/\\\/stoxpo.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/stoxpo.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/4q4p91-LogoMakr.png\",\"contentUrl\":\"https:\\\/\\\/stoxpo.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/4q4p91-LogoMakr.png\",\"width\":250,\"height\":250,\"caption\":\"Stoxpo\"},\"image\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#\\\/schema\\\/person\\\/031a96817fc4447b1046e0a10baad806\",\"name\":\"Luca Blaumann\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b7bbde6ef0582da5f93c9ff12262ea37de640f314250f9e3cfaeb37e258a563a?s=96&d=mm&r=g90dbb3a40c7379bca26d2b3dc92b368b\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b7bbde6ef0582da5f93c9ff12262ea37de640f314250f9e3cfaeb37e258a563a?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b7bbde6ef0582da5f93c9ff12262ea37de640f314250f9e3cfaeb37e258a563a?s=96&d=mm&r=g\",\"caption\":\"Luca Blaumann\"},\"description\":\"Luca is a proficient stock market reporter with a passion for dissecting complex market dynamics and uncovering transformative industry developments. With years of experience in leading editorial teams and overseeing coverage of the stock market and publicly traded companies, Luca has honed the ability to translate finance jargon into easily digestible articles. For tips and inquiries, reach out to Luca at tips@stoxpo.com.\",\"url\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/author\\\/luca-blaumann\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Moderna Reports Narrower Loss Amid Decline in Covid Vaccine Sales - Stoxpo","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/stoxpo.com\/index.php\/2024\/05\/02\/moderna-reports-narrower-loss-amid-decline-in-covid-vaccine-sales\/","og_locale":"en_US","og_type":"article","og_title":"Moderna Reports Narrower Loss Amid Decline in Covid Vaccine Sales - Stoxpo","og_description":"Biotech Company Reiterates Sales Guidance, Anticipates Launch of RSV Vaccine Moderna (MRNA), the biotech company at the forefront of Covid vaccine development, posted a narrower-than-expected loss for the first quarter as cost-cutting efforts and stronger-than-expected sales of its Covid vaccine bolstered its financial performance. Despite the decline in revenue from its flagship Covid shot, Moderna&#8217;s [&hellip;]","og_url":"https:\/\/stoxpo.com\/index.php\/2024\/05\/02\/moderna-reports-narrower-loss-amid-decline-in-covid-vaccine-sales\/","og_site_name":"Stoxpo","article_published_time":"2024-05-02T15:16:53+00:00","article_modified_time":"2024-05-02T15:16:54+00:00","og_image":[{"width":2560,"height":1707,"url":"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/pexels-mufid-majnun-9240711-scaled.jpg","type":"image\/jpeg"}],"author":"Luca Blaumann","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Luca Blaumann","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/stoxpo.com\/index.php\/2024\/05\/02\/moderna-reports-narrower-loss-amid-decline-in-covid-vaccine-sales\/#article","isPartOf":{"@id":"https:\/\/stoxpo.com\/index.php\/2024\/05\/02\/moderna-reports-narrower-loss-amid-decline-in-covid-vaccine-sales\/"},"author":{"name":"Luca Blaumann","@id":"https:\/\/stoxpo.com\/#\/schema\/person\/031a96817fc4447b1046e0a10baad806"},"headline":"Moderna Reports Narrower Loss Amid Decline in Covid Vaccine Sales","datePublished":"2024-05-02T15:16:53+00:00","dateModified":"2024-05-02T15:16:54+00:00","mainEntityOfPage":{"@id":"https:\/\/stoxpo.com\/index.php\/2024\/05\/02\/moderna-reports-narrower-loss-amid-decline-in-covid-vaccine-sales\/"},"wordCount":269,"publisher":{"@id":"https:\/\/stoxpo.com\/#organization"},"image":{"@id":"https:\/\/stoxpo.com\/index.php\/2024\/05\/02\/moderna-reports-narrower-loss-amid-decline-in-covid-vaccine-sales\/#primaryimage"},"thumbnailUrl":"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/pexels-mufid-majnun-9240711-scaled.jpg","articleSection":["Biotechnology","Large-Cap"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/stoxpo.com\/index.php\/2024\/05\/02\/moderna-reports-narrower-loss-amid-decline-in-covid-vaccine-sales\/","url":"https:\/\/stoxpo.com\/index.php\/2024\/05\/02\/moderna-reports-narrower-loss-amid-decline-in-covid-vaccine-sales\/","name":"Moderna Reports Narrower Loss Amid Decline in Covid Vaccine Sales - Stoxpo","isPartOf":{"@id":"https:\/\/stoxpo.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/stoxpo.com\/index.php\/2024\/05\/02\/moderna-reports-narrower-loss-amid-decline-in-covid-vaccine-sales\/#primaryimage"},"image":{"@id":"https:\/\/stoxpo.com\/index.php\/2024\/05\/02\/moderna-reports-narrower-loss-amid-decline-in-covid-vaccine-sales\/#primaryimage"},"thumbnailUrl":"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/pexels-mufid-majnun-9240711-scaled.jpg","datePublished":"2024-05-02T15:16:53+00:00","dateModified":"2024-05-02T15:16:54+00:00","breadcrumb":{"@id":"https:\/\/stoxpo.com\/index.php\/2024\/05\/02\/moderna-reports-narrower-loss-amid-decline-in-covid-vaccine-sales\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/stoxpo.com\/index.php\/2024\/05\/02\/moderna-reports-narrower-loss-amid-decline-in-covid-vaccine-sales\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/stoxpo.com\/index.php\/2024\/05\/02\/moderna-reports-narrower-loss-amid-decline-in-covid-vaccine-sales\/#primaryimage","url":"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/pexels-mufid-majnun-9240711-scaled.jpg","contentUrl":"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/pexels-mufid-majnun-9240711-scaled.jpg","width":2560,"height":1707,"caption":"moderna-vaccine-2"},{"@type":"BreadcrumbList","@id":"https:\/\/stoxpo.com\/index.php\/2024\/05\/02\/moderna-reports-narrower-loss-amid-decline-in-covid-vaccine-sales\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/stoxpo.com\/"},{"@type":"ListItem","position":2,"name":"Moderna Reports Narrower Loss Amid Decline in Covid Vaccine Sales"}]},{"@type":"WebSite","@id":"https:\/\/stoxpo.com\/#website","url":"https:\/\/stoxpo.com\/","name":"Stoxpo","description":"Stock Market &amp; Financial News","publisher":{"@id":"https:\/\/stoxpo.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/stoxpo.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/stoxpo.com\/#organization","name":"Stoxpo","url":"https:\/\/stoxpo.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/stoxpo.com\/#\/schema\/logo\/image\/","url":"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/4q4p91-LogoMakr.png","contentUrl":"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/4q4p91-LogoMakr.png","width":250,"height":250,"caption":"Stoxpo"},"image":{"@id":"https:\/\/stoxpo.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/stoxpo.com\/#\/schema\/person\/031a96817fc4447b1046e0a10baad806","name":"Luca Blaumann","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/b7bbde6ef0582da5f93c9ff12262ea37de640f314250f9e3cfaeb37e258a563a?s=96&d=mm&r=g90dbb3a40c7379bca26d2b3dc92b368b","url":"https:\/\/secure.gravatar.com\/avatar\/b7bbde6ef0582da5f93c9ff12262ea37de640f314250f9e3cfaeb37e258a563a?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/b7bbde6ef0582da5f93c9ff12262ea37de640f314250f9e3cfaeb37e258a563a?s=96&d=mm&r=g","caption":"Luca Blaumann"},"description":"Luca is a proficient stock market reporter with a passion for dissecting complex market dynamics and uncovering transformative industry developments. With years of experience in leading editorial teams and overseeing coverage of the stock market and publicly traded companies, Luca has honed the ability to translate finance jargon into easily digestible articles. For tips and inquiries, reach out to Luca at tips@stoxpo.com.","url":"https:\/\/stoxpo.com\/index.php\/author\/luca-blaumann\/"}]}},"_links":{"self":[{"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/posts\/2361","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/comments?post=2361"}],"version-history":[{"count":1,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/posts\/2361\/revisions"}],"predecessor-version":[{"id":2362,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/posts\/2361\/revisions\/2362"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/media\/1412"}],"wp:attachment":[{"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/media?parent=2361"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/categories?post=2361"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/tags?post=2361"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/coauthors?post=2361"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}